Cargando…
Older Age, a High Titre of Neutralising Antibodies and Therapy with Conventional DMARDs Are Associated with Protection from Breakthrough Infection in Rheumatoid Arthritis Patients after the Booster Dose of Anti-SARS-CoV-2 Vaccine
Objectives: We aimed to analyse the incidence and severity of breakthrough infections (BIs) in rheumatoid arthritis (RA) patients after a COronaVIrus Disease 2019 (COVID-19) vaccination booster dose. Methods: We enrolled 194 RA patients and 1002 healthcare workers (HCWs) as controls. Clinical, lifes...
Autores principales: | Picchianti-Diamanti, Andrea, Navarra, Assunta, Aiello, Alessandra, Laganà, Bruno, Cuzzi, Gilda, Salmi, Andrea, Vanini, Valentina, Maggi, Fabrizio, Meschi, Silvia, Matusali, Giulia, Notari, Stefania, Agrati, Chiara, Salemi, Simonetta, Di Rosa, Roberta, Passarini, Damiano, Di Gioia, Valeria, Sesti, Giorgio, Conti, Fabrizio, Spinelli, Francesca Romana, Corpolongo, Angela, Chimenti, Maria Sole, Ferraioli, Mario, Sebastiani, Gian Domenico, Benucci, Maurizio, Li Gobbi, Francesca, Santoro, Anna Paola, Capri, Andrea, Puro, Vincenzo, Nicastri, Emanuele, Goletti, Delia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675674/ https://www.ncbi.nlm.nih.gov/pubmed/38006015 http://dx.doi.org/10.3390/vaccines11111684 |
Ejemplares similares
-
SARS-CoV-2 Breakthrough Infections According to the Immune Response Elicited after mRNA Third Dose Vaccination in COVID-19-Naïve Hospital Personnel
por: Santoro, Annapaola, et al.
Publicado: (2023) -
Kinetics of the B- and T-Cell Immune Responses After 6 Months From SARS-CoV-2 mRNA Vaccination in Patients With Rheumatoid Arthritis
por: Farroni, Chiara, et al.
Publicado: (2022) -
Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Autoimmunity 1 Year Later: The Era of Vaccines
por: Picchianti Diamanti, Andrea, et al.
Publicado: (2021) -
Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants
por: Pallett, Scott J C, et al.
Publicado: (2022) -
The Third Dose of BNT162b2 COVID-19 Vaccine Does Not “Boost” Disease Flares and Adverse Events in Patients with Rheumatoid Arthritis
por: Picchianti Diamanti, Andrea, et al.
Publicado: (2023)